The dysregulation and hyperactivation of the canonical NF-κB pathway is linked with multiple pathologies including chronic inflammatory diseases such as inflammatory bowel disease [50], rheumatoid disease [51], and cancer [52]. This evidence concerns the gene NFKB1 and cancer.